Korea Investment Corp Abb Vie Inc. Transaction History

Korea Investment Corp

$41.3 Billion
Q3 2024

A detailed history of Korea Investment Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Korea Investment Corp holds 1,359,343 shares of ABBV stock, worth $232 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

1,359,343

Previous 1,242,055 9.44%

Holding current value

$232 Million

Previous $213 Million 26.01%

% of portfolio

0.65%

Previous 0.55%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$163.84 - $199.33 $19.2 Million - $23.4 Million	117,288 Added 9.44%	1,359,343 $268 Million
Q2 2024 Aug 13, 2024	SELL	$154.79 - $180.76 $28.7 Million - $33.6 Million	-185,721 Reduced 13.01%	1,242,055 $213 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $15.6 Million - $17.7 Million	-97,416 Reduced 6.39%	1,427,776 $260 Million
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $10.3 Million - $11.6 Million	74,883 Added 5.16%	1,525,192 $236 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $13.5 Million - $15.6 Million	101,085 Added 7.49%	1,450,309 $216 Million
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $13.5 Million - $16.8 Million	-102,013 Reduced 7.03%	1,349,224 $182 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $5.52 Million - $6.36 Million	-38,165 Reduced 2.56%	1,451,237 $231 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $8.06 Million - $9.67 Million	-58,298 Reduced 3.77%	1,489,402 $241 Million
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $1.51 Million - $1.73 Million	11,236 Added 0.73%	1,547,700 $208 Million
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $18.9 Million - $24 Million	136,988 Added 9.79%	1,536,464 $235 Million
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $33 Million - $40.9 Million	249,807 Added 21.73%	1,399,476 $227 Million
Q4 2021 Feb 09, 2022	BUY	$107.43 - $135.93 $8.25 Million - $10.4 Million	76,823 Added 7.16%	1,149,669 $156 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $6.12 Million - $6.95 Million	57,560 Added 5.67%	1,072,846 $116 Million
Q2 2021 Aug 12, 2021	BUY	$105.21 - $117.21 $2.57 Million - $2.86 Million	24,380 Added 2.46%	1,015,286 $114 Million
Q1 2021 May 13, 2021	SELL	$102.3 - $112.62 $11.5 Million - $12.6 Million	-112,204 Reduced 10.17%	990,906 $107 Million
Q4 2020 Feb 10, 2021	SELL	$80.49 - $108.67 $12.2 Million - $16.5 Million	-151,608 Reduced 12.08%	1,103,110 $118 Million
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $4.72 Million - $5.54 Million	-54,900 Reduced 4.19%	1,254,718 $110 Million
Q2 2020 Aug 12, 2020	BUY	$73.37 - $98.18 $28.9 Million - $38.6 Million	393,338 Added 42.93%	1,309,618 $129 Million
Q1 2020 May 14, 2020	SELL	$64.5 - $97.79 $10.6 Million - $16.1 Million	-165,000 Reduced 15.26%	916,280 $69.8 Million
Q4 2019 Feb 11, 2020	BUY	$72.13 - $90.25 $3.09 Million - $3.87 Million	42,900 Added 4.13%	1,081,280 $95.7 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $3.2 Million - $3.85 Million	50,800 Added 5.14%	1,038,380 $78.6 Million
Q2 2019 Aug 12, 2019	SELL	$65.7 - $83.98 $3.35 Million - $4.28 Million	-51,000 Reduced 4.91%	987,580 $71.8 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $1.97 Million - $2.31 Million	25,480 Added 2.52%	1,038,580 $83.7 Million
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $3.9 Million - $4.81 Million	-50,100 Reduced 4.71%	1,013,100 $93.4 Million
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $13.5 Million - $15 Million	-151,867 Reduced 12.5%	1,063,200 $101 Million
Q2 2018 Aug 13, 2018	SELL	$89.78 - $106.23 $942,690 - $1.12 Million	-10,500 Reduced 0.86%	1,215,067 $0
Q1 2018 May 09, 2018	BUY	$92.01 - $123.21 $2.03 Million - $2.72 Million	22,102 Added 1.84%	1,225,567 $116 Million
Q4 2017 Feb 12, 2018	BUY	$89.56 - $98.21 $11.4 Million - $12.5 Million	127,300 Added 11.83%	1,203,465 $116 Million
Q3 2017 Oct 25, 2017	BUY	$69.85 - $89.22 $75.2 Million - $96 Million	1,076,165	1,076,165 $95.6 Million

Others Institutions Holding ABBV

# of Institutions

3,869

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $302B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Korea Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Korea Investment Corp with notifications on news.

Account

Korea Investment Corp Abb Vie Inc. Transaction History